Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Stress and depression have been reported in gestational diabetes mellitus (GDM). Though inflammation and oxidative stress are associated with depression, there are no reports of link of cardiometabolic risks (CMR) to stress and depression in GDM. Normal pregnant women (control group, n = 164) and women with GDM (study group, n = 176) at 36th week of gestation were recruited for the study. Blood pressure (BP), body composition, heart rate variability (HRV), glycated hemoglobin (HbA1C), markers of insulin resistance, oxidative stress, inflammation and endothelial dysfunction, were assessed. Perceived stress score (PSS), quality of life (QoL) scale, Indian diabetic risk score (IDRS) and Edinburg postnatal depression score (EPDS) were assessed. Association of potential contributors to PSS and EDPS were assessed by correlation and regression analyses. There was significant increase in PSS, EPDS, IDRS scores, HbA1C, malondialdehyde (MDA) (oxidative stress marker) and high-sensitive C-reactive protein and interleukin-6 (inflammatory markers), and significant decrease in total power (TP) of HRV (marker of cardiovagal modulation), QoL and nitric oxide (endothelial dysfunction marker) in study group compared to control group. Though many cardiometabolic risk parameters were correlated with PSS and EPDS, the significant independent association was observed for TP, HbA1C, MDA and interleukin-6. However, interleukin-6 had maximum contribution to PSS (β = 0.550, p < 0.001) and EPDS (β = 0.393, p < 0.001) as demonstrated by multiple regression analysis. Inflammation, oxidative stress, glycation status and decreased cardiovagal modulation are associated with stress and depression at 36th week of gestation in GDM.
Stress and depression have been reported in gestational diabetes mellitus (GDM). Though inflammation and oxidative stress are associated with depression, there are no reports of link of cardiometabolic risks (CMR) to stress and depression in GDM. Normal pregnant women (control group, n = 164) and women with GDM (study group, n = 176) at 36th week of gestation were recruited for the study. Blood pressure (BP), body composition, heart rate variability (HRV), glycated hemoglobin (HbA1C), markers of insulin resistance, oxidative stress, inflammation and endothelial dysfunction, were assessed. Perceived stress score (PSS), quality of life (QoL) scale, Indian diabetic risk score (IDRS) and Edinburg postnatal depression score (EPDS) were assessed. Association of potential contributors to PSS and EDPS were assessed by correlation and regression analyses. There was significant increase in PSS, EPDS, IDRS scores, HbA1C, malondialdehyde (MDA) (oxidative stress marker) and high-sensitive C-reactive protein and interleukin-6 (inflammatory markers), and significant decrease in total power (TP) of HRV (marker of cardiovagal modulation), QoL and nitric oxide (endothelial dysfunction marker) in study group compared to control group. Though many cardiometabolic risk parameters were correlated with PSS and EPDS, the significant independent association was observed for TP, HbA1C, MDA and interleukin-6. However, interleukin-6 had maximum contribution to PSS (β = 0.550, p < 0.001) and EPDS (β = 0.393, p < 0.001) as demonstrated by multiple regression analysis. Inflammation, oxidative stress, glycation status and decreased cardiovagal modulation are associated with stress and depression at 36th week of gestation in GDM.
Introduction and Aim: Gestational diabetes mellitus (GDM), which is defined as diabetes diagnosed in the second and third trimesters of pregnancy, has emerged as a global public health concern. It has been associated with short-term and long-term adverse health outcomes for both mothers and their new-borns. Women with GDM are known to have decreased quality of life and increased risks of caesarean section, gestational hypertension, preeclampsia, and type 2 diabetes. In babies, GDM has been found to be associated with macrosomia or larger than normal gestational-aged infants, neonatal hypoglycemia, and type 2 diabetes mellitus later in life. Though yoga is known to improve the quality of life of diabetic patients, its role in the management of GDM has not been adequately assessed. Therefore, the present study was conducted to evaluate the effectiveness of Yoga on cardiometabolic parameters, psychophysical health and maternal and fetal outcomes in GDM patients at JIPMER hospital, Puducherry. Methods: Fifteen pregnant women diagnosed to have GDM, admitted to Obstetrics Ward of JIPMER Hospital were recruited for the study. The intervention package of a thirty minutes Yoga module consisting of Sukshma Vyayama (2 min), Tadasana (1 min), Utthitapadasana (1 min), Savasana in the left lateral posture (3 min), Nadisodhana or Anuloma-viloma pranayama (5 min), Chandranadi pranayama (5 min), Sheetali pranayama (5 min) and Bhramari pranayama (5 min) and Relaxation (3 min) was administered along with hospital routine treatment for 10 days during 35th/36th week (depending on the gestational week of admission to hospital), or until delivery. Cardiometabolic parameters including heart rate (HR), blood pressure (BP), rate pressure product (RPP) and glycemic status assessed by random blood sugar (RBS) were investigated. JIPMER hospital tool for the maternal and fetal outcome variables were used to assess the feto-maternal parameters. Perceived Stress Score (PSS) and Quality of Life Score (QoL) were used to assess the psychophysical health of the GDM patients. All the parameters were assessed before and after yoga intervention. Paired t test was used for statistical analysis of data. P value of <0.05 were considered to indicate significant statistical difference. Results: Statistically significant decrease in HR, BP, RPP, RBS, PSS, and increase in QoL, and improvement of fetomaternal outcomes (based on the normative data available in the department) were observed in GDM patients after yoga intervention for a period of seven to ten days during their hospital stay. Conclusion: A short-course yoga practice for 7-10 days is adequate to reduce cardiometabolic risks, psychological stress, and improve quality of life and feto-maternal outcomes in GDM patients. Antenatal mother with GDM can use yoga as an adjunct therapy in the later part of pregnancy to prevent or reduce the complications and to improve the maternal and fetal outcomes of gestational diabetes mellitus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.